Navigation Links
72% of Women Are Dissatisfied With Their Current Treatment of Vaginal Infection, Survey Finds

Foamix Offers New Intravaginal Foam Technology with Improved Usability &


NESS ZIONA, Israel, May 13 /PRNewswire/ -- Despite the high incidence of women's health conditions that require intra-vaginal drug delivery and the abundance of intravaginal creams, gels and ovules, a recent survey found that an alarming majority of women find their current treatment options "unacceptable" or "intolerable". The survey, conducted by Elixir-Applied Researches for Foamix, polled more than 200 women.

Findings show that the majority of females who have used intravaginal drugs find them dissatisfying because these products leak out of the vagina following treatment (72%), because of irritation, itch or bad smell (60%), or simply because they are inconvenient to use (58%). 82% of the panellists opined that they would trade their current medication for a new form that does not leak; and 65% would prefer a product that does not cause irritation, itch or bad smell.

Foamix develops foam delivery systems for intravaginal administration that expand gently in the vaginal cavity and evenly cover the entire vaginal surface for efficient treatment. The Foamix foams are administered in small and accurate amounts, (using metered dose valves). They are bioadhesive to reduce dosing frequency and are constituted of non-irritating ingredients. Notably, the Foamix foams are fully retained inside the vagina, resulting in non leakage and enhanced efficacy.

"It seems the majority of women are dissatisfied with the current intravaginal treatment options. Treatment inconvenience is known to result in poor treatment compliance and there is therefore still a need for new drug delivery systems that can be easily administered, enable adherence of drugs to the vaginal surface and do not leak out or cause irritation," says Arie Yeshaya, M.D., Senior Gynecologist at Rabin Medical Center, Israel (affiliated with Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel); and a women's health consultant to Foamix.

"The Foamix foam concept hits right on the spot of the drawbacks of current treatments," he adds.

"The Foamix intravaginal foam platform was developed with these difficulties in mind. We are working with major pharma companies to co-develop and market new intravaginal and dermal foam formulations," says Dr. Dov Tamarkin, CEO of Foamix Ltd.

About Foamix:

Headquartered in Ness Ziona, Israel, Foamix Ltd. is a leading developer of topical foams for dermatology and gynecology. Foamix's state-of-the-art foams provide controlled delivery of a variety of active ingredients. Foamix is a privately held company, whose business model is based on partnering with leading pharma companies to develop products utilizing its proprietary foam technologies. Foamix is currently collaborating with 10 pharmaceutical companies on 11 projects in the development of proprietary dermal and intravaginal drugs, and has its own in-house pipeline of dermatological and gynecological drugs in foam presentation. Foamix holds 4 US patents and has 64 US patents pending, with further filings worldwide.

For additional information please visit

Press inquiries:

Sigal Maymon, Foamix Ltd, +972-8-9316233 or

SOURCE Foamix Ltd
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
3. KGI and Smith College Establish Leadership Forum for Women in Bioscience
4. Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo
5. ABCs Private Practice Inaccurately Portrays Serious Womens Health Condition
6. National Survey Shows Most Women Are Not Satisfied With Their Progesterone Treatment
7. Federally-Funded Study Shows More Women Can Avoid Hysterectomy for Common Problem
8. Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Womens Biological Clock
9. Barr and Ortho Womens Health & Urology in Discussions to Settle ORTHO TRI-CYCLEN(R) LO Patent Litigation
10. Collaboration Sparks Creation of New Grand Rapids Laboratory Focused on Womens Health
11. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
Post Your Comments:
(Date:10/8/2015)... 8, 2015 The 2015 Nobel Prize in Chemistry ... Texas at Dallas. Aziz Sancar , who earned his ... in 1977, is one of three scientists who received ... and repair damaged DNA on a molecular level.  --> ... biology from UT Dallas in 1977, is ...
(Date:10/8/2015)... , Oct. 8, 2015  The ALS Association, ... ALS Assistive Technology Challenge to revolutionize communication technology solutions ... --> ALS (amyotrophic lateral sclerosis) is ... in the brain and the spinal cord. Eventually, people ... muscle movement, which often leads to total paralysis and ...
(Date:10/8/2015)... 2015  Today the Wyss Institute for Biologically Inspired ... start-up company Opsonix Inc. The announcement follows ... of Technology Development (OTD) and Opsonix Inc. enabling ... clinical use. --> ... people every year in the U.S. — more than ...
(Date:10/8/2015)... ... October 08, 2015 , ... Talon Innovations, a provider of ... other technology-driven industries, announces that it is one of three finalists for the Minnesota ... On Thursday, September 25 Talon Innovations was recognized as a nominee for this ...
Breaking Biology Technology:
... LAFAYETTE, Ind. - Researchers are developing a technology that ... efficient by using a new manufacturing method that employs ... to overcome two major obstacles that hinder widespread adoption ... and increase the efficiency of converting sunlight into an ...
... announces that a new market ... Diabetic Retinopathy Therapeutics - ... ... and Market Forecasts to 2017 ...
... March 9, 2011 SPX Corporation (NYSE: ... acquisition of B.W. Murdoch Ltd, a leading engineering company ... The company is based in Auckland, New Zealand. Terms ... engineering team has decades of experience in the New ...
Cached Biology Technology:
(Date:10/5/2015)... ) releases the following ... NXTD ), a biometric authentication company focused on the ... ) releases the following market and company update ... authentication company focused on the growing mobile commerce market. ... ) releases the following market and company update ...
(Date:9/30/2015)... 30, 2015  The U.S. Court of Appeals for ... ruling in favor of Crossmatch ™, affirming the ... company Suprema and its U.S. partner Mentalix violated Section ... provision that declares it unlawful to engage in "unfair ... of Crossmatch,s patents, the 5,900,993 patent and the 7,203,344 ...
(Date:9/28/2015)... , Sept. 28, 2015 CLEAR, ... that its expedited traveler service is coming ... transforms travel, bringing a frictionless experience, serious ... "CLEAR offers our travelers an ... service," said Jim Smith , Executive ...
Breaking Biology News(10 mins):
... A team of Virginia Tech researchers is working to characterize ... the goal of improving the quality and quantity of wood ... of genomics research is an important complement to the work ... ways to process woody biomass for biofuels," said Eric Beers, ...
... Pediatric neuroscientists at Oregon Health & Science University Doernbecher ... field strength MRI to reveal tiny white matter injuries ... Early, accurate identification of these lesions in ... and enable physicians to inform families sooner of the ...
... acknowledges the work of 22 young European scientists selected ... Programme. These scientists join a growing network of ... EMBO Young Investigators have the potential to be tomorrow,s ... and manager of the Young Investigator Programme. "They are ...
Cached Biology News:
... poor quality running into billions of ... under increasing pressure to reduce expensive ... microscopic distribution of ingredients is known ... as dissolution, stability, bio-availability and hardness. ...
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ID ...
... Sigmas FLAG Immunoprecipitation kit allows a ... of an active FLAG-tagged protein. The ... gel, which is a highly specific ... resin. The use of affinity resin ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ID clarifier: ...
Biology Products: